Stem cell transplant using partially matched donors for cancer or blood disorders
Part of Cancer clinical trials.
This trial uses a stem cell transplant from a partially matched family member or unrelated donor to treat cancer and other blood disorders. Because the donor isn't fully matched, the transplant uses a special method to select certain stem cells (CD34-selected) to help reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a disease (like cancer or a blood disorder) that can be helped by a stem cell transplant.
- You don't have a fully matched sibling donor, so you need a donor who is half-matched (family member) or a 7/8-matched unrelated volunteer.
- Your donor must be able to receive a medicine to boost stem cells and have a procedure to collect their stem cells.
- You must be healthy enough for a transplant, with well-working major organs and no major infections.
- If you are a woman who could become pregnant, you must not be pregnant.
- You must agree to the treatment plan; if you are under 18, your parent or guardian must sign consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether a specific stem cell transplant method (from a related “half-matched” donor) plus conditioning chemo and radiation can improve outcomes for several blood cancers. It may help people whose cancer is in remission but still considered high risk, or those who have had limited response after prior treatment.
This trial offers a stem cell transplant using a half-matched family donor and/or cord blood for people with high-risk or hard-to-treat cancers or blood disorders. It aims to provide a treatment option when a perfectly matched donor is not available.
This trial studies a type of stem cell transplant (bone marrow transplant) that uses a donor who is only half-matched to the patient, often a parent or sibling. It is for children and young adults with certain blood diseases, including sickle cell disease, thalassemia, bone marrow failure, and immune disorders. The transplant aims to replace the diseased blood-forming cells with healthy ones from the donor.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This trial tests a type of stem cell transplant that removes certain immune cells (alpha-beta T cells and CD19 B cells) from the donor cells. This may help prevent graft-versus-host disease and other complications in patients with blood cancers who do not have a matched sibling donor.
This trial provides a special type of stem cell transplant for people under 22 years old who don't have a fully matched sibling donor. It uses a method to remove certain cells from the donor's stem cells to reduce the risk of graft-versus-host disease, where the donor cells attack the patient's body.
Hear when a new Benign Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.